Information to Patients : Health Organisations Urge Meps to Reject Commission Proposals
Ahead of the European Parliament's vote on the directive on information to patients, which will take place on 23 November, four health organisations have called on MEPs to oppose the European Commission's proposals with regard to the public provision of information relating to drugs subjected to medical regulation, specifically for a directive to modify Directive 2001/83/CE and a regulation to modify (EC)726/2004. In a 16 November letter, the Association Internationale de la Mutualite (AIM), Health Action International (HAI) Europe, the International Society of Drug Bulletins (ISDB) and the Medicines in Europe Forum (MiEF) have objected to pharmaceutical companies being the sole judge of how and when to provide information on their products to patients.
In adopting reports by Christopher Fjellner (EPP, Sweden), on 28 September, environment and public health officials focused proposals on patients' interests and limited direct information. Thus, a minimum of information, such as the approved contents and the most recent summaries of the product's characteristics and labelling was suggested by the evaluation report, which added that these should be made available via restricted media, namely a website for this specific …
Questia, a part of Gale, Cengage Learning. www.questia.com
Publication information: Article title: Information to Patients : Health Organisations Urge Meps to Reject Commission Proposals. Contributors: Not available. Magazine title: European Social Policy. Publication date: December 6, 2010. Page number: 283784. © 2009 Europolitics. COPYRIGHT 2010 Gale Group.
This material is protected by copyright and, with the exception of fair use, may not be further copied, distributed or transmitted in any form or by any means.